Vancouver-based women’s fashion retailer Aritzia Inc. (ATZ:TSX) is drawing significant attention from analysts, with one expert projecting a potential upside of up to 35 per cent for its shares. This optimistic outlook follows the company’s ‘impressive’ first-quarter earnings report, which has prompted a wave of price target hikes across the analyst community.
UBS Global Research analyst Mauricio Serna is among the most bullish, having raised his price target for Aritzia to $216 from $204 in a note dated July 10. This revised target suggests a substantial increase from the stock’s closing price of $160.05 on Friday. Serna’s confidence stems from Aritzia’s robust first-quarter performance, which saw net revenue surge by 43 per cent, alongside strong growth observed in both the United States and Canada.
Aritzia’s Strong Fundamentals Drive Optimism
Serna highlighted several strategic advantages underpinning his positive forecast. ‘We believe ATZ’s investments in differentiated store concepts, increasing brand relevance, diversified product assortment, and digital marketing initiatives should drive compelling long-term growth,’ he stated. He also cited the chain’s impressive 35 per cent year-over-year growth in comparable sales, a ‘strong’ outlook for the second quarter, and better-than-expected guidance for 2027.
RBC Capital Markets analyst Irene Nattel also increased her price target for Aritzia to $202 from $193, characterizing the latest quarter as ‘impressive.’ Nattel and Serna were among 10 analysts who collectively hiked their price targets. Shares of Aritzia climbed nearly eight per cent on Friday, though they remain below their all-time high of $173.20 recorded in mid-June. According to Bloomberg, the average 12-month price target from 14 analysts stands at $189.14.
RBC Capital Markets Adds Canadian Stocks to Global Top Ideas
RBC Capital Markets has updated its list of top 30 global stock ideas for the third quarter, adding two S&P/TSX composite index stocks: Canadian National Railway Co. (CNR:TSX) and the recently publicly listed Apotex Health Corp. (APTX:TSX).
Greame Pearson, head of RBC Global Research, noted CNR shares are trading at a discount despite improving fundamentals. He cited ‘Record grain volumes, intermodal share gains, and pricing running ahead of inflation’ as underpinning a solid earnings growth outlook, with ongoing capacity investments positioning CN for ‘meaningful operating leverage.’ Apotex was added due to its leading position in the Canadian generic drug sector (23 per cent market share) and a top-10 ranking in the U.S. market. Pearson believes Apotex ‘should successfully harness improving industry fundamentals… capturing a disproportionate amount of economic value.’ The top-30 list posted an 11.1 per cent total return in U.S. dollars. Other TSX-listed names include AltaGas Ltd. (ALA:TSX), Constellation Software Inc. (CSU:TSX), and Loblaw Cos. Ltd. (L:TSX).
Raymond James Adjusts Metals Price Targets
In commodities, Raymond James analysts, led by Bruce MacArthur, have reviewed their metals coverage. Gold’s price continues to sputter, trading on July 10 below its year-start and down 24 per cent from its record high of just over US$5,400 an ounce in January.
The team updated price targets for base and precious metals. Copper emerged as their top pick, with analysts hiking price targets due to anticipated supply shortages. ‘As a result of the copper price forecast changes, we are broadly increasing price targets across the base metal producers under coverage,’ they stated, naming Freeport McMoRan Inc. (FCX:NYSE) and Hudbay Minerals Inc. (HBM:TSX) as leading picks. Conversely, price targets for precious metals producers saw a ‘broad’ reduction, though preferred names include Agnico Eagle Mines Ltd. (AEM:TSX) for lower geographic risk and OceanaGold Corp. (OGC:TSX) for improving production. Raymond James remains bullish on uranium, recommending Cameco Corp. (CCO:TSX), NexGen Energy Ltd. (NXE:TSX), and Denison Mines Corp. (DML:TSX).
The recent analyst upgrades for Aritzia, driven by strong earnings and strategic growth, highlight optimism within the Canadian market. These assessments, alongside broader market insights from RBC Capital Markets and Raymond James, offer investors a detailed view of potential movements across diverse sectors.
